Hitachi with Alfresa’s

Hitachi Constructs Japan’s First Platform for Integrated Management of Cell and Tracing Information throughout the Value Chain for Regenerative Medicine Products through Collaborative Creation with Alfresa and Others

Hitachi, Ltd. (TSE:6501) has constructed a platform for the integrated management of cell and tracing information throughout the value chain, from cell collection, through production and transport, to the administration of regenerative

August 31, 2020

News

Hitachi with Alfresa's

Hitachi Constructs Japan’s First Platform for Integrated Management of Cell and Tracing Information throughout the Value Chain for Regenerative Medicine Products through Collaborative Creation with Alfresa and Others

About

Categories

Social Links